Browsing by Author "Sevindik, Ömür"
Now showing items 1-2 of 2
-
Rituximab-vemurafenib combination for the treatment of relapsed/Refractory hairy cell leukemia
Sevindik, Ömür; Gemici, Aliihsan; Mutlu, Yaşa Gül; Balık Aydın, Berrin; Çakır, Aslı (CIG Media Group, 2020)Objective: The management of R/R-HCL is not standardized yet. Patients with HCL universally harbor BRAF mutations, which makes BRAF inhibitors a potential treatment approach. The effi cacy and safety of the BRAF inhibitor ...